{"id":181329,"name":"NOVO NORDISK INC.","slug":"novo-nordisk-inc","state":"DC","description":"A global healthcare company focused on diabetes and other serious chronic diseases","totalSpending":1140000,"filings":19,"yearlySpending":[{"year":2020,"income":180000},{"year":2021,"income":240000},{"year":2022,"income":300000},{"year":2024,"income":180000},{"year":2025,"income":240000}],"firms":["TARPLIN, DOWNS & YOUNG, LLC"],"lobbyists":["CHARLOTTE IVANCIC","RAISSA DOWNS","JENNIFER YOUNG","MICHELLE EASTON","ELIZABETH MURRAY","PAMELA SMITH","EMILY MURRY","KIMBERLY BRANDT","MARGARET JOSEPH","PETER FISE","LAURA FRIEDEL","PARICK CARROLL"],"issues":["DEF","TAX","BUD","GOV","MMM","CPT","HCR","PHA"],"sampleDescriptions":["Issues related to diabetes and obesity","Issues related to implementation of P.L. 115-97 Tax Cuts and Jobs Act of 2017","H.R. 4710 Pharmaceutical Independence Long-Term Readiness Reform Act and related \"Buy American\" procurement issues.","H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020\nH.R. 6201 - Families First Coronavirus Response Act\nS. 3548 - CARES Act\n\nMedication affordability and access; general diabetes prevention; S. 1948/H.R. 3709 Chronic Disease Management Act and general issues related to High Deductible Health Plan pre-deductible coverage of treatments and services for chronic diseases; implementation of P.L. 115-80 (H.R. 309/S. 920) Clinical Care Commission Act; S. 2199/H.R. 4906 Insulin Price Reduction Act; H.R. 3 Elijah Cummings Lower Drug Costs Now Act; S. 1895 Lower Health Care Costs Act; H.R. 19/S 3129 Lower Costs, More Cures Act","H.R. 1530/S. 595 Treat and Reduce Obesity Act; H.R. 1840/S. 814 Expanding Access to DSMT Act (Diabetes Self-Management Training); Medicare Diabetes Prevention Program; issues related to podiatric services; issues related to diabetic vision loss and blindness prevention; CMS coverage of diabetes technologies/services; virtual Medicare Diabetes Prevention Program (DPP) diabetes self-management education; issues related to Medicare Part D; issues related to International Price Indexing (IPI)/reference pricing in Medicare; H.R. 107 related to maximum Medicaid rebates; Medicare Part D Rebate Rule; 6 Protected Classes in Medicare Part D; S.2543 Prescription Drug Pricing Reduction Act","H.R. 2584/S. 1361 Preventive Health Savings Act (issues related to CBO scoring of preventive health services); \"Buy American\" procurement issues in PL 116-136 Coronavirus Aid, Relief, and Economic Security (CARES) Act; CMS Authority to Provide Coverage for Anti-Obesity Agents Under Part D in FY21 Labor-HHS-Education Appropriations.","H.R. 1520 Purple Book Continuity Act of 2019; H.R. 1503 Orange Book Transparency Act of 2019; issues related to importation; issues related to 340B; H.R. 4244 MAGIC (Market Access for Generic Insulin Competition) Act to provide for a pathway for chemically synthesized insulin to be approved under an abbreviated new drug application submitted under the Federal Food, Drug, and Cosmetic Act)","Issues related to lobbying disclosure and political participation for US affiliates in H.R. 1 For the People Act.","Medication affordability and access; general diabetes prevention; S. 1948/H.R. 3709 Chronic Disease Management Act and general issues related to High Deductible Health Plan pre-deductible coverage of treatments and services for chronic diseases; implementation of P.L. 115-80 (H.R. 309/S. 920) Clinical Care Commission Act; S. 2199/H.R. 4906 Insulin Price Reduction Act; H.R. 3 Elijah Cummings Lower Drug Costs Now Act; S. 1895 Lower Health Care Costs Act; H.R. 19/S. 3129 Lower Costs, More Cures Act","H.R. 1530/S. 595 Treat and Reduce Obesity Act and obesity treatment in COVID-19 relief; H.R. 1840/S. 814 Expanding Access to DSMT Act (Diabetes Self-Management Training); Medicare Diabetes Prevention Program; issues related to podiatric services; issues related to diabetic vision loss and blindness prevention; CMS coverage of diabetes technologies/services; virtual Medicare Diabetes Prevention Program (DPP) diabetes self-management education; issues related to Medicare Part D; issues related to International Price Indexing (IPI)/reference pricing in Medicare; H.R. 107 related to maximum Medicaid rebates; Medicare Part D Rebate Rule; 6 Protected Classes in Medicare Part D; S.2543 Prescription Drug Pricing Reduction Act","H.R. 2584/S. 1361 Preventive Health Savings Act (issues related to CBO scoring of preventive health services); \"Buy American\" procurement issues in PL 116-136 Coronavirus Aid, Relief, and Economic Security (CARES) Act; CMS Authority to Provide Coverage for Anti-Obesity Agents Under Part D in FY21 Labor-HHS-Education Appropriations; H.R. 8337 Continuing Appropriations Act, 2021 and Other Extensions Act (issues related to expiring health programs)","Medication affordability and access; general diabetes prevention; S. 1948/H.R. 3709 Chronic Disease Management Act and general issues related to High Deductible Health Plan pre-deductible coverage of treatments and services for chronic diseases; implementation of P.L. 115-80 (H.R. 309/S. 920) Clinical Care Commission Act; S. 2199/H.R. 4906 Insulin Price Reduction Act; H.R. 3 Elijah Cummings Lower Drug Costs Now Act; S. 1895 Lower Health Care Costs Act; H.R. 19/S. 3129 Lower Costs, More Cures Act; H.R. 133 Consolidated Appropriations Act, 2021","H.R. 1530/S. 595 Treat and Reduce Obesity Act and obesity treatment in COVID-19 relief; H.R. 1840/S. 814 Expanding Access to DSMT Act (Diabetes Self-Management Training); Medicare Diabetes Prevention Program; issues related to podiatric services; issues related to diabetic vision loss and blindness prevention; CMS coverage of diabetes technologies/services; virtual Medicare Diabetes Prevention Program (DPP) diabetes self-management education; issues related to Medicare Part D; issues related to International Price Indexing (IPI)/reference pricing in Medicare; H.R. 107 related to maximum Medicaid rebates; Medicare Part D Rebate Rule; 6 Protected Classes in Medicare Part D; S.2543 Prescription Drug Pricing Reduction Act; H.R. 133 Consolidated Appropriations Act, 2021","H.R. 2584/S. 1361 Preventive Health Savings Act (issues related to CBO scoring of preventive health services); \"Buy American\" procurement issues in PL 116-136 Coronavirus Aid, Relief, and Economic Security (CARES) Act; CMS Authority to Provide Coverage for Anti-Obesity Agents Under Part D in FY21 Labor-HHS-Education Appropriations; H.R. 8337 Continuing Appropriations Act, 2021 and Other Extensions Act (issues related to expiring health programs); H.R. 133 Consolidated Appropriations Act, 2021","issues related to 340B","Medication affordability and access, general diabetes prevention, obesity","H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 and obesity treatment in COVID-19 relief; H.R.1319 American Rescue Plan Act of 2021 and issues related to Medicaid rebates; Part D redesign","deficit reduction; S. Con. Res. 5 (117); H.R.1319 American Rescue Plan Act of 2021 and issues related to the coverage of obesity therapeutics in Medicare","Issues related to corporate tax","H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 and obesity treatment in COVID-19 relief; H.R. 1319, American Rescue Plan of 2021 implementation and issues related to Medicaid rebates; Part D redesign"],"years":[2020,2021,2022,2024,2025]}